NJRetina
Edison, New Jersey 08820
2 studies enrolling now · 13 studies all time
What they study most
Age-Related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD), Geographic Atrophy of the Macula, Macular Degeneration, Macular Neovascularization Secondary to Age-Related Macular Degeneration, Neovascular Age Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion, Wet Age Related Macular Degeneration
Studies at this site
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — Recruiting now
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD — Recruiting now
- A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
- 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
- A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema — Completed
- A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
- IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD — Completed
- A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) — Completed
- A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) — Completed
- Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD). — Stopped early
- Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. — Completed
- Resistance to Antibiotics in Patients Receiving Eye Injections — Completed